Corteva (NYSE:CTVA) Price Target Raised to $89.00

by · The Markets Daily

Corteva (NYSE:CTVA – Get Free Report) had its price target boosted by stock analysts at UBS Group from $86.00 to $89.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price suggests a potential upside of 17.07% from the stock’s current price.

CTVA has been the topic of several other research reports. Rothschild & Co Redburn lifted their price objective on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. CICC Research raised their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Finally, BMO Capital Markets raised their price objective on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $91.38.

Get Our Latest Stock Analysis on Corteva

Corteva Trading Down 3.4%

Shares of CTVA stock traded down $2.69 on Monday, hitting $76.03. The stock had a trading volume of 7,953,587 shares, compared to its average volume of 4,047,788. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a twelve month low of $60.53 and a twelve month high of $90.97. The company has a fifty day moving average price of $82.15 and a two-hundred day moving average price of $79.63. The firm has a market cap of $50.85 billion, a P/E ratio of 50.35, a PEG ratio of 2.39 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter last year, the business posted $2.20 EPS. The firm’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts forecast that Corteva will post 3.75 earnings per share for the current fiscal year.

Institutional Trading of Corteva

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Tema ETFs LLC raised its holdings in Corteva by 10.4% during the second quarter. Tema ETFs LLC now owns 10,774 shares of the company’s stock worth $912,000 after acquiring an additional 1,015 shares in the last quarter. City Holding Co. grew its stake in Corteva by 2.6% in the second quarter. City Holding Co. now owns 25,086 shares of the company’s stock valued at $2,124,000 after purchasing an additional 635 shares in the last quarter. Sax Wealth Advisors LLC bought a new stake in shares of Corteva during the 2nd quarter worth approximately $237,000. Avity Investment Management Inc. boosted its holdings in shares of Corteva by 14.4% in the 2nd quarter. Avity Investment Management Inc. now owns 5,172 shares of the company’s stock valued at $438,000 after buying an additional 650 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its holdings in Corteva by 8.3% during the second quarter. Valeo Financial Advisors LLC now owns 6,963 shares of the company’s stock worth $589,000 after buying an additional 536 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Company Profile

(Get Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Further Reading